FENC
Fennec Pharmaceuticals Inc
NASDAQ: FENC · HEALTHCARE · BIOTECHNOLOGY
$6.26
-6.57% today
Updated 2026-04-29
Market cap
$235.81M
P/E ratio
—
P/S ratio
5.28x
EPS (TTM)
$-0.34
Dividend yield
—
52W range
$6 – $10
Volume
0.2M
Fennec Pharmaceuticals Inc (FENC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-21.80%
Operating margin
-18.50%
ROE
-65.80%
ROA
-6.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-19.10M | — | — | — |
| 2007 | — | $-13.36M | — | — | — |
| 2008 | — | $-13.60M | — | — | — |
| 2009 | — | $-3.01M | — | — | — |
| 2010 | — | $-7.82M | — | — | — |
| 2011 | $0.00 | $4.68M | — | — | — |
| 2012 | $0.00 | $-5.16M | — | — | — |
| 2013 | $0.00 | $1.84M | — | — | — |
| 2014 | $0.00 | $-2.18M | — | — | — |
| 2015 | $0.00 | $-659000.00 | — | — | — |
| 2016 | $0.00 | $-2.79M | — | — | — |
| 2017 | $0.00 | $-7.05M | — | — | — |
| 2018 | $0.00 | $-9.89M | — | — | — |
| 2019 | $0.00 | $-12.46M | — | — | — |
| 2020 | $170000.00 | $-18.11M | 100.00% | -10,520.59% | -10,652.35% |
| 2021 | $170000.00 | $-17.19M | — | -10,042.03% | -10,113.75% |
| 2022 | $1.47M | $-22.77M | 94.40% | -1,471.60% | -1,544.89% |
| 2023 | $21.25M | $-16.05M | 94.08% | -60.09% | -75.50% |
| 2024 | $47.54M | $-436000.00 | 93.30% | 5.40% | -0.92% |
| 2025 | $45.42M | $-10.27M | 91.57% | -15.11% | -22.62% |